These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1777593)

  • 1. Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis.
    Ziegler TR; Lazarus JM; Young LS; Hakim R; Wilmore DW
    J Am Soc Nephrol; 1991 Dec; 2(6):1130-5. PubMed ID: 1777593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of recombinant human growth hormone in CAPD patients.
    Ikizler TA; Wingard RL; Breyer JA; Schulman G; Parker RA; Hakim RM
    Kidney Int; 1994 Oct; 46(4):1178-83. PubMed ID: 7861714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Aguilera A; Burgués S; Martínez-Ara J; Miguel JL; Gómez-Pan A; Selgas R
    Am J Kidney Dis; 1998 Sep; 32(3):454-63. PubMed ID: 9740162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of human growth hormone combined with nutritional support in a critical care unit.
    Ziegler TR; Young LS; Ferrari-Baliviera E; Demling RH; Wilmore DW
    JPEN J Parenter Enteral Nutr; 1990; 14(6):574-81. PubMed ID: 2273531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients.
    Fouque D; Peng SC; Shamir E; Kopple JD
    Kidney Int; 2000 Feb; 57(2):646-54. PubMed ID: 10652043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculated nitrogen balance in hemodialysis patients: influence of protein intake.
    Rao M; Sharma M; Juneja R; Jacob S; Jacob CK
    Kidney Int; 2000 Jul; 58(1):336-45. PubMed ID: 10886580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function.
    Wang M; Obi Y; Streja E; Rhee CM; Lau WL; Chen J; Hao C; Hamano T; Kovesdy CP; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1118-1127. PubMed ID: 28487345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin-induced changes in protein nutrition: quantitative assessment by urea kinetic modeling analysis.
    Canaud B; Bouloux C; Rivory JP; Taib J; Garred LJ; Florence P; Mion C
    Blood Purif; 1990; 8(5):301-8. PubMed ID: 2091690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting survival of hemodialysis patients utilizing urea kinetic modeling. A critical appraisal of shortening dialysis times.
    Capelli JP; Kushner H; Camiscioli T; Chen SM; Stuccio-White NM
    Am J Nephrol; 1992; 12(4):212-23. PubMed ID: 1481868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing hemodialysis using a weekly urea mass balance model.
    Leypoldt JK; Kablitz C; Gregory MC; Senekjian HO; Cheung AK
    Blood Purif; 1991; 9(5-6):271-84. PubMed ID: 1819316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year growth hormone therapy improves granulocyte function without major effects on nutritional and anthropometric parameters in malnourished hemodialysis patients.
    Kotzmann H; Schmidt A; Lercher P; Schuster E; Geyer G; Frisch H; Hörl WH; Mayer G; Luger A
    Nephron Clin Pract; 2003; 93(2):C75-82. PubMed ID: 12616034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients.
    Garibotto G; Barreca A; Russo R; Sofia A; Araghi P; Cesarone A; Malaspina M; Fiorini F; Minuto F; Tizianello A
    J Clin Invest; 1997 Jan; 99(1):97-105. PubMed ID: 9011582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of protein catabolic rate in patients on chronic intermittent hemodialysis: urea output measurements compared with dietary protein intake and with calculation of urea generation rate.
    Stegeman CA; Huisman RM; de Rouw B; Joostema A; de Jong PE
    Am J Kidney Dis; 1995 Jun; 25(6):887-95. PubMed ID: 7771485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics.
    Depner TA; Daugirdas JT
    J Am Soc Nephrol; 1996 May; 7(5):780-5. PubMed ID: 8738814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of recombinant human growth hormone in patients receiving parenteral nutrition.
    Ziegler TR; Young LS; Manson JM; Wilmore DW
    Ann Surg; 1988 Jul; 208(1):6-16. PubMed ID: 3133995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients.
    Lorenzo V; Martín M; Rufino M; Jiménez A; Malo AM; Sanchez E; Hernández D; Rodríguez M; Torres A
    Am J Kidney Dis; 2001 Jun; 37(6):1260-6. PubMed ID: 11382697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerance of medical nutritional products as sole sources of nutrition in people on hemodialysis.
    Cockram DB; Hensley MK; Rodriguez M; Agarwal G; Wennberg A; Ruey P; Ashbach D; Hebert L; Kunau R
    J Ren Nutr; 1998 Jan; 8(1):25-33. PubMed ID: 9724827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related decline in serum parathyroid hormone in maintenance hemodialysis patients is independent of inflammation and dietary nutrient intake.
    Mehrotra R; Supasyndh O; Berman N; Kaysen G; Hurst L; Leonardi M; Das D; Kopple JD
    J Ren Nutr; 2004 Jul; 14(3):134-42. PubMed ID: 15232791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine Kt/V and Normalized Protein Nitrogen Appearance Rate Determined From Conductivity Access Clearance With Infrequent Postdialysis Serum Urea Nitrogen Measurements.
    Raimann JG; Ye X; Kotanko P; Daugirdas JT
    Am J Kidney Dis; 2020 Jul; 76(1):22-31. PubMed ID: 32220509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.